Overview

Study on Cerebral Protection of Dexmedetomidine for Patients With Traumatic Brain Injury

Status:
Recruiting
Trial end date:
2021-12-30
Target enrollment:
Participant gender:
Summary
The aim of the study is to investigate whether dexmedetomidine could suppress catecholamine release into peripheral blood to prevent PSH attacks and to achieve neuroprotection.
Phase:
Phase 4
Details
Lead Sponsor:
Xiangya Hospital of Central South University
Treatments:
Dexmedetomidine
Midazolam